Helsinki, Finland

Pentti T Nore


Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 75(Granted Patents)


Company Filing History:


Years Active: 1991-2008

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Inventive Journey of Pentti T. Nore

Introduction

Pentti T. Nore, an accomplished inventor based in Helsinki, Finland, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 11 patents, he has been at the forefront of innovative research aimed at developing therapies for critical health conditions.

Latest Patents

Among his latest inventions, Nore has developed therapeutically active compounds defined by a specific formula. These compounds act as potent inhibitors of the Na/Ca exchange mechanism, showcasing their potential in treating various medical conditions. Additionally, he has also worked on pyridazinyl phenyl hydrazones that are particularly useful against congestive heart failure, further demonstrating his dedication to address serious health challenges through innovation.

Career Highlights

Throughout his career, Nore has been associated with prominent companies such as Orion-yhtyma Oy and Orion Corporation, both of which have provided a platform for his inventive work. His experience in these organizations has equipped him with the expertise to lead significant research initiatives and contribute to advancements in the pharmaceutical industry.

Collaborations

Nore's innovative journey has also been shaped by collaborations with talented professionals in the field. Notable among his coworkers are Heimo O. Haikala and Erkki J. Honkanen, with whom he has worked closely to enhance the development and efficacy of his patentable inventions.

Conclusion

Pentti T. Nore's contributions to the realm of pharmaceuticals through his innovative patents and collaborations highlight his role as a pioneer in his field. His work continues to inspire new therapeutic developments and advances in patient care, establishing him as a key figure in the current landscape of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…